HeyJaredThe IMID Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
- Indexed episodes, last 90 days
- 8
- Latest publication
- Sep 3, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 9, 2026
Latest episodes
Author Interview: Doctor Elise van Mulligen, September 2026 (opens the original)
Read excerpt
Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they discuss her recent paper ‘Long-term durability of a time-limited methotrexate intervention in patients with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibodynegative arthralgia at increased risk for rheumatoid arthritis (TREAT EARLIER): 5-year data from a double-blind, randomised, placebo-con
Discussing RA: Biologic effectiveness and treatment persistence in RA (opens the original)
Read excerpt
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and Charles‑Schoeman et al, in which authors the impact of shared epitope positivity on bDMARD effectiveness and compare treatment persistence and switching to UPA versus other advanced therapies after TNFi failure.
Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety (opens the original)
Read excerpt
Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores recent advances in PsA and immune-mediated inflammatory disease therapies.
Author Interview: Professor Axel Finckh and Associate Professor Bente Glintborg, August 2026 (opens the original)
Read excerpt
Join Professor Peter Nash from the Griffith University in Brisbane; Professor Axel Finckh, from the Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland; and Bente Glintborg, an Associate Professor from the Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark as they discuss his recent paper ‘Influence of the shared epitope on the effectiveness of biologic antirheumatic agents in European patients with rheumatoid arthritis’.
Discussing RA: Advanced therapy outcomes in RA (opens the original)
Read excerpt
Join Professor Iain McInnes and Doctor Philip Mease for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, they examine key findings from studies by Fleischmann et al. and Nozaki et al. discussing the long-term effectiveness and safety of advanced targeted therapies for RA.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.